Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
25,000
﹤0.01% 159
2026
Q1
$15K Hold
25,000
﹤0.01% 156
2025
Q4
$9K Hold
25,000
﹤0.01% 157
2025
Q3
$9K Hold
25,000
﹤0.01% 161
2025
Q2
$11K Hold
25,000
﹤0.01% 149
2025
Q1
$10K Hold
25,000
﹤0.01% 147
2024
Q4
$17K Buy
25,000
+12,500
+100% +$8.68K ﹤0.01% 151
2024
Q3
$8K Hold
12,500
﹤0.01% 138
2024
Q2
$8K Hold
12,500
﹤0.01% 138
2024
Q1
$16K Hold
12,500
﹤0.01% 136
2023
Q4
$7K Hold
12,500
﹤0.01% 141
2023
Q3
$9K Hold
12,500
﹤0.01% 134
2023
Q2
$9K Buy
+12,500
New +$11.6K ﹤0.01% 137

Other funds holding VXRT

LVM Capital Management's VXRT Position: Q2 2026 in Review

LVM Capital Management held its Vaxart (VXRT) position steady in Q2 2026 at 25,000 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

LVM Capital Management first reported a position in VXRT in Q2 2023 and has held it in 13 quarters since. The position peaked at $17K in Q4 2024. 2 funds tracked by Wall St. Rank hold VXRT as of Q2 2026.

  • LVM Capital Management held 25,000 shares of Vaxart worth $15K as of Q2 2026.
  • LVM Capital Management left its Vaxart share count unchanged in Q2 2026.
  • Vaxart made up ﹤0.01% of LVM Capital Management's portfolio in Q2 2026, its #159 holding.
  • LVM Capital Management first reported a position in Vaxart in Q2 2023 and has held it in 13 quarters since.
  • LVM Capital Management's Vaxart position peaked at $17K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Vaxart as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.